Search Results - "VANHAM, G."

HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru by VERDONCK, K., GONZÁLEZ, E., SCHROOTEN, W., VANHAM, G., GOTUZZO, E.

“…The purpose of this study was to assess the association between human T-lymphotropic virus 1 (HTLV-1) and a lifetime history of active tuberculosis (TB) among…”
Get full text

A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression by Quiñones-Mateu, M E, Ball, S C, Marozsan, A J, Torre, V S, Albright, J L, Vanham, G, van Der Groen, G, Colebunders, R L, Arts, E J

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Nonviral transfection of distinct types of human dendritic cells : High-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells by VAN TENDELOO, V. F. I, SNOECK, H.-W, VERDONK, P, VAN BOCKSTAELE, D. R, BERNEMAN, Z. N, LARDON, F, VANHAM, G. L. E. E, NIJS, G, LENJOU, M, HENDRIKS, L, VAN BROECKHOVEN, C, MOULIJNI, A, RODRIGUS, I

“…Human dendritic cells (DC) are highly professional antigen presenting cells for the priming of naive cytotoxic T cells. Gene transfer in DC would be a useful…”
Get full text

The "gatekeeper" hypothesis challenged in a human cervico-vaginal tissue model for HIV-1 transmission by Ariën, K K, Gali, Y, Vanham, G

Get full text

Proviral load and immune markers associated with human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru by Best, I., Adaui, V., Verdonck, K., González, E., Tipismana, M., Clark, D., Gotuzzo, E., Vanham, G.

“…Summary Human T‐lymphotropic virus type 1 (HTLV‐1) is the aetiological agent of HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). The…”
Get full text

Efficient stimulation of HIV-1–specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins by Van Gulck, Ellen R.A., Ponsaerts, Peter, Heyndrickx, Leo, Vereecken, Katleen, Moerman, Filip, De Roo, Ann, Colebunders, Robert, Van den Bosch, Glenn, Van Bockstaele, Dirk R., Van Tendeloo, Viggo F.I., Allard, Sabine, Verrier, Bernard, Marañón, Concepción, Hoeffel, Guillaume, Hosmalin, Anne, Berneman, Zwi N., Vanham, Guido

“…Infection with human immunodeficiency virus type 1 (HIV-1) is characterized by dysfunction of HIV-1–specific T cells. To control the virus, antigen-loaded…”
Get full text

P04-34. Identification of 4E10-like antibodies in plasma of an HIV-1 CRF02_AG infected patient with broad neutralizing activity using peptide phage libraries by Dieltjens, T, Willems, B, Heyndrickx, L, Vanham, G

Get full text

HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru by VERDONCK, K, GONZALEZ, E, HENOSTROZA, G, NABETA, P, LLANOS, F, CORNEJO, H, VANHAM, G, SEAS, C, GOTUZZO, E

“…SETTING: Tuberculosis (TB) and human T-lymphotropic virus 1 (HTLV-1) are frequent in Peru. The prevalence of HTLV-1 among Peruvian TB patients is…”
Get full text

O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? by P. Pannus, P. Adams, E. Willems, L. Heyndrickx, M. Van Frankenhuijsen, E. Florence, M. Kiselinova, S. Rutsaert, K. Vervisch, W. Despiegelaere, C. Devaux, L. Vandekerckhove, G. Vanham

Get full text

P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein by Grupping, K, Heyndrickx, L, Michiels, J, Martin, G, Martin, L, Vanham, G

Get full text

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization by Heyndrickx, L, Stewart-Jones, G, Schuitemaker, H, Bowles, E, Buonaguro, L, Jansson, M, Grevstad, B, Vinner, L, Ramaswamy, M, Biswas, P, Scarlatti, G, Vanham, G, Fomsgaard, A

“…Doc number: P17…”
Get full text

P18-08. Characterization of CD34+ derived dendritic cells generated in vitro and transfected with HIV gene as potential therapeutic vaccine in macaque by Romain, G, Van Gulck, E, Zurawski, G, Banchereau, J, Vanham, G, Le Grand, R, Martinon, F

“…Dendritic cells (DC) transfected with messenger ribonucleic acids (mRNA) encoding endogenous viral proteins are expected to enhance the HIV specific immune…”
Get full text

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection by Nyambi, P N, Burda, S, Williams, C, Heyndrickx, L, Vanham, G, Gorny, M K

Get full text

P04-52 LB. The importance of well-defined HIV-1 neutralization assays by Balla-Jhagjhoorsingh, SS, Willems, B, Vereecken, K, Heyndrickx, L, Davis, D, Corti, D, Lanzavecchia, A, Weiss, R, Vanham, G

“…Monoclonal antibodies were then isolated from memory B cells of individuals whose plasma cross-neutralized strains from multiple subtypes in a high throughput…”
Get full text

Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models by MAERTEN, P., SHEN, C., COLPAERT, S., LIU, Z., BULLENS, D. A. M., VAN ASSCHE, G., PENNINCKX, F., GEBOES, K., VANHAM, G., RUTGEERTS, P., CEUPPENS, J. L.

“…SUMMARY An imbalance of immunoregulatory factors and/or cells contributes to uncontrolled mucosal T cell activation and inflammation in Crohn's disease (CD)…”
Get full text

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV by Meuwissen, PJ, Ariën, KK, Vandewalle, I, Naessens, E, Vanderstraeten, H, Taghon, T, Vanham, G, Fackler, OT, Kirchhoff, F, Saksela, K, Verhasselt, B

“…Frontiers of Retrovirology 2011 Amsterdam, The Netherlands 3-5 October 2011 Author details1-Ghent University, HIVlab, Department of Clinical Chemistry,…”
Get full text

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections by Njai, H F, Tomusange, K, Sokolik-Wolak, B, Montefiori, D, Balla, S, Vanham, G, Levin, J, Maher, D, Kamali, A, Grosskurth, H, Pala, P, Kaleebu, P

Get full text

Ex vivo induction of viral antigen‐specific CD8+ T cell responses using mRNA‐electroporated CD40‐activated B cells by Van den Bosch, G. A., Ponsaerts, P., Nijs, G., Lenjou, M., Vanham, G., Van Bockstaele, D. R., Berneman, Z. N., Van Tendeloo, V. F. I.

“…Summary Cell‐based immunotherapy, in which antigen‐loaded antigen‐presenting cells (APC) are used to elicit T cell responses, has become part of the search for…”
Get full text

Selective increase of activation antigens HLA‐DR and CD38 on CD45RO+ T lymphocytes during HIV‐1 infection by KESTENS, L., VANHAM, G., VEREECKEN, C., VANDENBRUAENE, M., VERCAUTEREN, G., COLEBUNDERS, R. L., GIGASE, P. L.

“…SUMMARY Infection with HIV results in a progressive depletion of CD4* T cells and leads to significant in vivo lymphocyte phenotype changes. In this regard,…”
Get full text

T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB) by Hertoghe, T, Wajja, A, Ntambi, L, Okwera, A, Aziz, M.A, Hirsch, C, Johnson, J, Toossi, Z, Mugerwa, R, Mugyenyi, P, Colebunders, R, Ellner, J, Vanham, G

“…Immune parameters were compared in four groups of Ugandan subjects: HIV⁻and HIV⁺ adult patients with active pulmonary TB (HIV⁻ PTB n = 38; HIV⁺ PTB n = 28),…”
Get full text